Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Elicera Therapeutics

5.54 SEK

-0.89 %

Less than 1K followers

ELIC

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Elicera Therapeutics

P/B

Median 2021-2025

 
2019202020212022202320242025
Share price (SEK)--5.023.524.561.675.22
Shares19.819.819.819.819.835.148.5
Market cap--99.369.590.258.6253.4
Enterprise value--46.9----
EV/S--79.9----
EV/EBITDA--neg.----
EV/EBIT--neg.----
P/E--neg.neg.neg.neg.neg.
P/B--1.902.125.502.8210.85
P/S--169.2----
Dividend yield--0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio-81.3 %95.4 %70.8 %54.3 %75.4 %85.2 %
Gearing ratio-------
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.